Complement 4 Levels as Early Predictors of Poor Response to Surfactant Therapy in Respiratory Distress Syndrome

ABSTRACT

The aim was to determine whether stronger complement activation is an early predictor of poor response to surfactant treatment in infants with severe respiratory distress syndrome (RDS). Thirty-one preterm newborns with severe RDS (initial fraction of inspired oxygen [FiO₂] > 0.5) and 22 healthy preterm newborns were studied. The study group was divided into two subgroups according to their response to natural surfactant 6 hours after administration: good responders had reduction in FiO₂ > 50% of the presurfactant level, and poor responders had a reduction in FiO₂ ≤ 50%. Levels of complement 4 (C4) and C3c were measured in blood samples drawn at admission and 24 hours after birth. The poor responders to surfactant had significantly lower serum C4 levels at admission and in the first day of life than the good responders. The poor responders also had lower C3c levels at birth than the good responders, but higher C3c levels at 24 hours. Receiver-operator curve analysis revealed that, compared with C3c at admission, C4 at admission was a more sensitive and specific predictor of poor response to surfactant treatment in preterm newborns with severe RDS (area under the curve, 0.863; 95% confidence interval, 0.726 to 1; p = 0.001). Significantly decreased serum C4 at admission is a valuable early predictor of poor response prior to surfactant treatment in preterm newborns with severe RDS. C4 level may help investigators determine the mechanisms underlying poor responsiveness to surfactant.

KEYWORDS

Complement 4 - surfactant therapy - respiratory distress syndrome

REFERENCES

• 1 Weigelt J A, Chenoweth D E, Borman K R, Norcross J F. Complement and the severity of pulmonary failure.  J Trauma. 1988;  28 1013-1019
• 2 Saugstad O, Buo L, Johansen H, Roise O, Aasen A. Activation of the plasma kallikrein-kinin system in respiratory distress syndrome.  Pediatr Res. 1992;  32 431-435
• 3 Brus F, van Oeveren W, Okken A, Oetomo S B. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.  Pediatr Res. 1994;  36 647-653
• 4 Brus F, van Oeveren W, Okken A, Oetomo S B. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome.  Pediatr Res. 1996;  39 456-463
• 5 Wagner M H, Sonntag J, Strauss E, Obladen M. Contact activation related to surfactant response in respiratory distress syndrome.  Pediatr Res. 1999;  45 14-18
• 6 Sonntag J, Stiller B, Walka M M, Maier R F. Anaphylotoxins in fresh-frozen plasma.  Transfusion. 1997;  37 798-803
• 7 Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP).  Pediatr Radiol. 1973;  1 145-152
• 8 Segerer H, Stevens P, Schadow B et al.. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.  Pediatr Res. 1991;  30 591-596
• 9 Soldin S J, Hicks J M, Bailey J, Beatey J, Cook J F. Pediatric reference ranges for complement factors C3 and C4.  Clin Chem. 1998;  44 A14
• 10 Schrod L, Frauendienst E G, Von Stockhausen H B, Kirschfink M. Complement fragment C3a in plasma of asphyxiated neonates.  Eur J Pediatr. 1992;  151 688-692
• 11 Zilow E P, Hauck W, Linderkamp O, Zilow G. Alternative pathway activation of the complement system in preterm infants with early onset infection.  Pediatr Res. 1997;  41 334-339
• 12 Sonntag J, Wagner M H, Strauss E, Obladen M. Complement and contact activation in term newborns after fetal acidosis.  Arch Dis Child Fetal Neonatal Ed. 1998;  78F 125-128
• 13 Groneck P, Oppermann M, Speer C P. Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infantsat risk for chronic lung disease and effect of dexamethasone treatment.  Pediatr Res. 1993;  34 586-590
• 14 Carvalho A C, Demarinis S, Scott C F, Silver L D, Schamaier A H, Colman R W. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.  J Lab Clin Med. 1980;  112 270-277
• 15 Hammerschmidt D E, Hudson L D, Weaver L J, Craddock P R, Jacob H S. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome: pathophysiological relevance and possible prognostic value.  Lancet. 1980;  8175 947-949
• 16 Royall J A, Levin D L. Adult respiratory distress syndrome in pediatric patients. I: Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury.  J Pediatr. 1988;  112 169-180